Company Overview and News

 
4 Impressive Earnings Yield Stocks to Boost Your Portfolio

2018-04-20 zacks
If you are uncertain whether to invest your money in stocks or bonds, one key financial metric that can show you the right way is earnings yield. It is the inverse of the price-to-earnings (P/E) ratio and can be used for detecting undervalued stocks. Moreover, the ratio can be effectively used for comparing stocks with the market or fixed income securities. Earnings Yield can be defined as (Annual Earnings per Share/Market Price) x 100.
Upvote Downvote

1
7 Retirement Stocks for the Coming Correction

2018-04-18 investorplace
I’ve long believed that one of the worst strategies in the market is for investors to “rotate” into so-called defensive stocks. It’s a common piece of advice from experts, particularly in a more volatile market. The strategy sounds cautious, and even wise. In a nervous market, investors should migrate to lower-risk stocks in order to protect their capital.
Upvote Downvote

 
Will Q1 Earnings be a Treat for These 4 Homebuilding Stocks?

2018-04-17 zacks
The Q1 earnings season is gathering steam and investors are eagerly awaiting results from major homebuilders, which have remained in the spotlight throughout the quarter for a number of reasons. The quarter witnessed massive volatility on uncertainty over the number of interest rate hikes and inconsistent monthly homebuilding data. Evidently, the S&P Homebuilders Select Industry Index has dropped 8.
Upvote Downvote

 
4 Top Stocks to Build a Position in Q2 Housing Recovery

2018-04-16 investorplace
The housing sector had fallen out of favor in the first quarter of 2018 with high prices, rising rents and interest rates doing the damage. However, a rebound is now palpable, with millennials contributing to most of the sector’s gains.
Upvote Downvote

 
10 Bulletproof Blue-Chip Growth Stocks to Invest In

2018-04-16 investorplace
Given the recent employment report that was released earlier this morning, it looks like the U.S. economy is just getting started.
Upvote Downvote

 
Lennar (LEN) to Gain From Acquisitions, Weak Margins Hurt

2018-04-16 zacks
Lennar Corporation’s (LEN - Free Report) diversified line of home offerings for first-time, move-up and active adult homebuyers, and positive housing market fundamentals are the driving factors for this leading homebuilder in the United States. Additionally, synergies from its recent acquisitions are also encouraging. Recently, this leading homebuilder reported stellar first quarter of fiscal 2018 results wherein earnings as well as revenues surpassed the Zacks Consensus Estimate by 20.
Upvote Downvote

 
KBH / KB Home 8-K (Current Report)

2018-04-13 sec.gov
Document UNITED STATES
Upvote Downvote

 
KBH / KB Home 8-A12B/A

2018-04-13 sec.gov
Document
Upvote Downvote

 
AeroVironment upgraded to buy from hold at Stifel Nicolaus

2018-04-11 marketwatch
Shares of drone maker AeroVironment Inc. fell more than 8% late Tuesday after the company swung to a surprise fiscal 2018 third-quarter loss. AeroVironment said it lost $800,000, or 4 cents a share, in the third quarter of fiscal 2018, compared with a net loss of $2.2 million, or 9 cents a share, in the year-ago period. Revenue rose 20% to $64 million, compared with $53.2 million a year ago. Analysts polled by FactSet had expected earnings of 2 cents a share on sales of $63 million.
Upvote Downvote

 
Top Ranked Growth Stocks to Buy for April 10th

2018-04-10 zacks
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 10th:
Upvote Downvote

 
Can KB Home (KBH) Stock Continue to Grow Earnings?

2018-04-10 zacks
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses. One such company that might be well-positioned for future earnings growth is KB Home (KBH - Free Report) .
Upvote Downvote

 
Zacks.com featured highlights include: HD Supply, Arch Coal, Fiat, Methanex and Korn/Ferry

2018-04-10 zacks
Chicago, IL – April 10, 2018 - Stocks in this week’s article Fiat Chrysler Automobiles N.V. (FCAU - Free Report) , HD Supply Holdings, Inc. (HDS - Free Report) , Arch Coal, Inc. (ARCH), Methanex Corporation (MEOH - Free Report) and Korn/Ferry International (KFY - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Pioneer Natural, Chemours, Louisiana-Pacific and Timken

2018-04-10 zacks
Chicago, IL – April 10, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Pioneer Natural Resources Company (PXD - Free Report) , Chemours Company (CC - Free Report) , Louisiana-Pacific Corporation (LPX - Free Report) and Timken Company (TKR - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Cirrus, Qorvo, Infineon and Apple

2018-04-10 zacks
Chicago, IL – April 10, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Cirrus Logic, Inc. (CRUS - Free Report) , Qorvo, Inc. (QRVO - Free Report) , Infineon Technologies AG (IFNNY - Free Report) and Apple Inc.
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Triumph, Pacific Premier, Commerce Bancshares, PacWest and Southside Bancshares

2018-04-10 zacks
Chicago, IL – April 10, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Triumph Bancorp, Inc. (TBK - Free Report) , Pacific Premier Bancorp, Inc. (PPBI - Free Report) , Commerce Bancshares, Inc. (CBSH - Free Report) , PacWest Bancorp (PACW - Free Report) and Southside Bancshares, Inc.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 48666K109